Literature DB >> 18031230

Daxx mediates SUMO-dependent transcriptional control and subnuclear compartmentalization.

H-M Shih1, C-C Chang, H-Y Kuo, D-Y Lin.   

Abstract

SUMO (small ubiquitin-related modifier) modification is emerging as an important post-translational control in transcription. In general, SUMO modification is associated with transcriptional repression. Although many SUMO-modified transcription factors and co-activators have been identified, little is known about the mechanism underlying SUMOylation-elicited transcriptional repression. Here, we summarize that SUMO modification of transcription factors such as androgen receptor, glucocorticoid receptor, Smad4 and CBP [CREB (cAMP-response-element-binding protein)-binding protein] co-activator results in the recruitment of a transcriptional co-repressor Daxx, thereby causing transcriptional repression. Such a SUMO-dependent recruitment of Daxx is mediated by the interaction between the SUMO moiety of SUMOylated factors and Daxx SUMO-interacting motif. Interestingly, the transrepression effect of Daxx on these SUMOylated transcription factors can be relieved by SUMOylated PML (promyelocytic leukaemia) via altering Daxx partition from the targeted gene promoter to PML nuclear bodies. Because Daxx SUMO-interacting motif is a common binding site for SUMOylated factors, a model of competition for Daxx recruitment between SUMOylated PML and SUMOylated transcription factors was proposed. Together, our findings strongly suggest that Daxx functions as a SUMO reader in the SUMO-dependent regulation of transcription and subnuclear compartmentalization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18031230     DOI: 10.1042/BST0351397

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  29 in total

Review 1.  The role of cysteine oxidation in DJ-1 function and dysfunction.

Authors:  Mark A Wilson
Journal:  Antioxid Redox Signal       Date:  2011-01-14       Impact factor: 8.401

2.  Baculovirus IE2 Interacts with Viral DNA through Daxx To Generate an Organized Nuclear Body Structure for Gene Activation in Vero Cells.

Authors:  Sung-Chan Wei; Chih-Hsuan Tsai; Wei-Ting Hsu; Yu-Chan Chao
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

3.  Regulation of Signal Transduction by DJ-1.

Authors:  Stephanie E Oh; M Maral Mouradian
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

4.  Targeting Smad4 links microRNA-146a to the TGF-beta pathway during retinoid acid induction in acute promyelocytic leukemia cell line.

Authors:  Hua Zhong; Hai-rong Wang; Shuang Yang; Ji-hua Zhong; Ting Wang; Chun Wang; Fang-yuan Chen
Journal:  Int J Hematol       Date:  2010-06-25       Impact factor: 2.490

5.  Regulation of ICP0-null mutant herpes simplex virus type 1 infection by ND10 components ATRX and hDaxx.

Authors:  Vera Lukashchuk; Roger D Everett
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

6.  Role of SUMOylation in full antiestrogenicity.

Authors:  Khalid Hilmi; Nader Hussein; Rodrigo Mendoza-Sanchez; Mohamed El-Ezzy; Houssam Ismail; Chantal Durette; Martine Bail; Maria Johanna Rozendaal; Michel Bouvier; Pierre Thibault; James L Gleason; Sylvie Mader
Journal:  Mol Cell Biol       Date:  2012-07-23       Impact factor: 4.272

7.  The SUMO ligase PIAS1 regulates UV-induced apoptosis by recruiting Daxx to SUMOylated foci.

Authors:  Raghavi Sudharsan; Yoshiaki Azuma
Journal:  J Cell Sci       Date:  2012-09-12       Impact factor: 5.285

8.  Daxx is a transcriptional repressor of CCAAT/enhancer-binding protein beta.

Authors:  Nils Wethkamp; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

9.  Human cytomegalovirus protein pp71 induces Daxx SUMOylation.

Authors:  Jiwon Hwang; Robert F Kalejta
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

10.  Repressive effects of resveratrol on androgen receptor transcriptional activity.

Authors:  Wen-feng Shi; Melanie Leong; Ellen Cho; Joseph Farrell; Han-chun Chen; Jun Tian; Dianzheng Zhang
Journal:  PLoS One       Date:  2009-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.